-
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT07227532 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 22 Years and older ·
Sex: All (male and female)
· Illinois: Naperville
-
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT06455098 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Illinois: Glenview
-
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
NCT03907046 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Arlington Heights, Chicago, Evanston, Maywood
-
BoxX-NoAF Clinical Trial
NCT06989775 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 65 Years and older ·
Sex: All (male and female)
· Illinois: Chicago
-
CardioFocus HeartLight Post-Approval Study
NCT03168659 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Chicago
-
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
NCT05723926 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Rockford
-
Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
NCT06056271 ·
Phase: Not specified ·
Ages: 21 Years and older ·
Sex: All (male and female)
· Illinois: Evanston
-
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
NCT06784466 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Illinois: Springfield
-
Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
NCT06376916 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Oak Lawn
-
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
NCT07308847 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Illinois: Chicago
-
MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
NCT05978466 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Chicago
-
NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
NCT06511505 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 40 Years and older ·
Sex: All (male and female)
· Illinois: Chicago
-
PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF
NCT07324772 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 60 Years to 99 Years ·
Sex: All (male and female)
· Illinois: Chicago
-
PULSED AF Post-Approval Study
NCT06578104 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Chicago
-
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
NCT06957366 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Evanston
-
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
NCT06844227 ·
Phase: Not specified ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Illinois: Evanston
-
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
NCT02347111 ·
Phase: Phase 4 ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Illinois: Chicago, Oak Lawn
-
Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone
NCT06063538 ·
Phase: Early Phase 1 ·
Ages: 20 Years to 85 Years ·
Sex: All (male and female)
· Illinois: Chicago
-
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
NCT04088071 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Evanston, Naperville, Springfield
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
NCT06735534 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Oak Lawn
-
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
NCT06499857 ·
Phase: Phase 3 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· Illinois: Chicago
-
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200 ·
Phase: Phase 3 ·
Ages: 65 Years and older ·
Sex: All (male and female)
· Illinois: Park Ridge, Rockford, Winfield
-
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Evanston, Rock Island
-
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
NCT05836987 ·
Phase: Phase 3 ·
Ages: 22 Years to 85 Years ·
Sex: All (male and female)
· Illinois: Chicago, Elk Grove Village, Evanston, Naperville
-
Vasoactive Drugs in Intensive Care Unit
NCT02118467 ·
Phase: Phase 4 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Illinois: Chicago